Onetime, potentially curative treatments for hemophilia represent the first 'big wave' in the gene therapy space. Moderated by David Carr of PRECISIONadvisors, join us as we explore the challenges, and discuss solutions to getting new and innovative gene therapy therapies into the hands of patients who need them most.
Join Precision and Akara Group for a special live, online discussion of best practices for pre-launch commercialization activities.
Historic unemployment rates have dramatically shifted healthcare coverage trends as a result of COVID-19. Join our upcoming live webinar on Wednesday, July 15th, 12:00 PM EDT, with PRECISIONadvisors' Greg Gregory and Eddie Vogel, and learn we can address the impact of these shifts, and help support your teams' ability to answer tough questions moving forward.
Why Biotech Should Develop A Market Access Strategy From Early On & How To Do It
Launching a drug requires a robust strategy to understanding payer decision-making. In this webinar with Precision's Brett DiNatale and Diego Etcheto, learn how our rigorous, standardized, 3-step methodology can help you predict future actions for your entire payer spectrum.
In this on-demand webinar, a panel of Precision's top gene and cell therapy leaders tackles the challenge of how to demonstrate the short and long-term value of a therapy when clinical data is lacking.
Adapted from recent presentations at the AMCP and ISPOR conferences, this webinar will provide an overview of value-based contracting and some of the key challenges to successful implementation.
This expert panel tackle head-on some of the hottest topics and trends in health economics and outcomes research today, and what you need to know to be successful in 2020.